Ashutosh P Jadhav1, Cynthia L Kenmuir1, Amin Aghaebrahim1, Kaustubh Limaye1, Lawrence R Wechsler1, Maxim D Hammer1, Matthew T Starr1, Bradley J Molyneaux1, Marcelo Rocha1, Francis X Guyette1, Christian Martin-Gill1, Andrew F Ducruet1, Bradley A Gross1, Brian T Jankowitz1, Tudor G Jovin2. 1. From the Department of Neurology (A.P.J., C.L.K., K.L., L.R.W., M.D.H., M.T.S., B.J.M., M.R., B.A.G., B.T.J., T.G.J.), Department of Neurosurgery (A.P.J., B.J.M., B.A.G., B.T.J., T.G.J.), Department of Critical Care Medicine (B.J.M.), and Department of Emergency Medicine (F.X.G., C.M.-G.), University of Pittsburgh Medical Center, PA; Baptist Neurological Institute, Jacksonville, FL (A.A.); and Barrow Neurological Institute, Phoenix, AZ (A.F.D.). 2. From the Department of Neurology (A.P.J., C.L.K., K.L., L.R.W., M.D.H., M.T.S., B.J.M., M.R., B.A.G., B.T.J., T.G.J.), Department of Neurosurgery (A.P.J., B.J.M., B.A.G., B.T.J., T.G.J.), Department of Critical Care Medicine (B.J.M.), and Department of Emergency Medicine (F.X.G., C.M.-G.), University of Pittsburgh Medical Center, PA; Baptist Neurological Institute, Jacksonville, FL (A.A.); and Barrow Neurological Institute, Phoenix, AZ (A.F.D.). jovitg@upmc.edu.
Abstract
BACKGROUND AND PURPOSE: In patients identified at referring facilities with acute ischemic stroke caused by a large vessel occlusion, bypassing the emergency department (ED) with direct transport to the neuroangiography suite may safely shorten reperfusion times. METHODS: We conducted a single-center retrospective review of consecutive patients transferred to our facility for consideration of endovascular therapy. Patients were identified as admitted directly to the neuroangiography suite (DAN), transferred to the ED before intra-arterial therapy (ED-IA), and transferred to the ED but did not receive IA therapy (ED-IV). RESULTS: A retrospective review of a prospectively maintained database of transfer patients between January 2013 and October 2016 with large vessel occlusions identified 108 ED-IV patients and 261 patients who underwent mechanical thrombectomy (DAN=111 patients and ED-IA=150 patients). There were no differences in baseline characteristics among the 3 groups. The median computed tomography ASPECTS (Alberta Stroke Program Early CT Score) was lower in the ED-IV group versus the ED-IA and DAN groups (8 versus 9; P=0.001). In the DAN versus ED-IA cohort, there were comparable rates of TICI2b/3 recanalization and access to recanalization time. There was significantly faster hospital arrival to groin access time in the DAN cohort (81 minutes versus 22 minutes; P=0.001). Functional independence at 90 days was comparable in the DAN versus ED-IA cohorts but worse in the ED-IV group (43% versus 44% versus 22%; P=0.001). CONCLUSIONS: DAN is safe, feasible, and associated with faster times of hospital arrival to recanalization. The clinical benefit of this approach should be assessed in a prospective randomized trial.
BACKGROUND AND PURPOSE: In patients identified at referring facilities with acute ischemic stroke caused by a large vessel occlusion, bypassing the emergency department (ED) with direct transport to the neuroangiography suite may safely shorten reperfusion times. METHODS: We conducted a single-center retrospective review of consecutive patients transferred to our facility for consideration of endovascular therapy. Patients were identified as admitted directly to the neuroangiography suite (DAN), transferred to the ED before intra-arterial therapy (ED-IA), and transferred to the ED but did not receive IA therapy (ED-IV). RESULTS: A retrospective review of a prospectively maintained database of transfer patients between January 2013 and October 2016 with large vessel occlusions identified 108 ED-IV patients and 261 patients who underwent mechanical thrombectomy (DAN=111 patients and ED-IA=150 patients). There were no differences in baseline characteristics among the 3 groups. The median computed tomography ASPECTS (Alberta Stroke Program Early CT Score) was lower in the ED-IV group versus the ED-IA and DAN groups (8 versus 9; P=0.001). In the DAN versus ED-IA cohort, there were comparable rates of TICI2b/3 recanalization and access to recanalization time. There was significantly faster hospital arrival to groin access time in the DAN cohort (81 minutes versus 22 minutes; P=0.001). Functional independence at 90 days was comparable in the DAN versus ED-IA cohorts but worse in the ED-IV group (43% versus 44% versus 22%; P=0.001). CONCLUSIONS:DAN is safe, feasible, and associated with faster times of hospital arrival to recanalization. The clinical benefit of this approach should be assessed in a prospective randomized trial.
Authors: Radoslav I Raychev; Dana Stradling; Nirav Patel; Joey R Gee; David A Lombardi; Johnson L Moon; David M Brown; Mayank Pathak; Wengui Yu; Samuel J Stratton; Steven C Cramer Journal: Stroke Date: 2018-04-06 Impact factor: 7.914
Authors: Shreyansh Shah; Ying Xian; Shubin Sheng; Kori S Zachrison; Jeffrey L Saver; Kevin N Sheth; Gregg C Fonarow; Lee H Schwamm; Eric E Smith Journal: Circulation Date: 2019-03-26 Impact factor: 29.690
Authors: A T Yu; R W Regenhardt; C Whitney; L H Schwamm; A B Patel; C J Stapleton; A Viswanathan; J A Hirsch; M Lev; T M Leslie-Mazwi Journal: AJNR Am J Neuroradiol Date: 2021-02-04 Impact factor: 3.825
Authors: Esmee Venema; Adrien E Groot; Hester F Lingsma; Wouter Hinsenveld; Kilian M Treurniet; Vicky Chalos; Sanne M Zinkstok; Maxim J H L Mulder; Inger R de Ridder; Henk A Marquering; Wouter J Schonewille; Marieke J H Wermer; Charles B L M Majoie; Yvo B W E M Roos; Diederik W J Dippel; Jonathan M Coutinho; Bob Roozenbeek Journal: Stroke Date: 2019-04 Impact factor: 7.914
Authors: Alex Brehm; Ioannis Tsogkas; Johanna M Ospel; Christian Appenzeller-Herzog; Junya Aoki; Kazumi Kimura; Johannes A R Pfaff; Markus A Möhlenbruch; Manuel Requena; Marc J Ribo; Amrou Sarraj; Alejandro M Spiotta; Peter Sporns; Marios-Nikos Psychogios Journal: Ther Adv Neurol Disord Date: 2022-03-02 Impact factor: 6.570
Authors: Marios-Nikos Psychogios; Ilko L Maier; Ioannis Tsogkas; Amélie Carolina Hesse; Alex Brehm; Daniel Behme; Marlena Schnieder; Katharina Schregel; Ismini Papageorgiou; David S Liebeskind; Mayank Goyal; Mathias Bähr; Michael Knauth; Jan Liman Journal: J Clin Med Date: 2019-12-11 Impact factor: 4.241
Authors: Laura C C van Meenen; Nerea Arrarte Terreros; Adrien E Groot; Manon Kappelhof; Ludo F M Beenen; Henk A Marquering; Bart J Emmer; Yvo B W E M Roos; Charles B L M Majoie; Jonathan M Coutinho Journal: J Neurointerv Surg Date: 2021-03-08 Impact factor: 5.836